Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 1
Posted on January 12, 2026
Robert Dream, Managing Director, HDR Company LLC
Advanced Therapy Medicinal Products (ATMPs) Technology transfer (TT) refers to the process of transferring the necessary knowledge, processes, and technologies from research and development (R&D) to manufacturing, and eventually to the commercial production of ATMPs. However, several challenges ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Advanced Therapy Medicinal Products, Apligraf, ATMPs, CAR-T, CAR-T therapies, cell therapie, EMA, European Medicines Agency, FDA, gene therapie, GMP, Good Manufacturing Practices, ICH, Manufacturing Scale-Up, Process Development and Optimization, R&D, Regulatory Challenges, U.S. Food and Drug Administration, WHO, World Health Organization
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
